RxDoctor Payments Data

Justin Poore, DO

Family Medicine · Concordia, KSNPI 1306849161

Payments from drug & device makers

$1,596in general payments, 2019–2025

Across 99 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$384
  • Pfizer$288
  • Amgen$193
  • Novo Nordisk$176
  • Lilly USA, LLC$142
  • Novartis$111
  • plus $303 from 13 others

What the payments were for

  • Food & beverage$1,596100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,596 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$41,013
Medicare patients
149
Services billed
620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban193$122,247
OzempicSemaglutide36$35,764
FarxigaDapagliflozin Propanediol29$26,973
XareltoRivaroxaban12$20,381
JardianceEmpagliflozin36$18,093
TrulicityDulaglutide13$13,612
MounjaroTirzepatide12$12,620
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,573
Lantus SolostarInsulin Glargine,hum.Rec.Anlog51$8,240
Combivent RespimatIpratropium/Albuterol Sulfate16$7,749
SymbicortBudesonide/Formoterol Fumarate29$7,116
PaxlovidNirmatrelvir/Ritonavir14$5,772
Novolog FlexpenInsulin Aspart25$5,228
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen219$5,181
Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm30$4,817

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$288$128,018207 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$61$45,66276 claims
Novo NordiskOzempic$176$35,76436 claims
Lilly USA, LLCTrulicity, Mounjaro, Humulin 70-30$142$29,93757 claims
AbbVieViibryd$384$4,31412 claims
GSKArnuity Ellipta$28$3,07313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Concordia

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →